Stock Picking - Art Or Science

If there is one Legal way to Become Rich early, it is by Investing in Stocks and Real Estate. In this Blog you will not see general news which are available at numerous sites, instead u will get filtered news and opinions which matter. Many a times some small but important news were overlooked because of simultaneous big event, I try to put all those news in my Blog. The Home Page shows posts of only last 10 days. To see all the posts click on the month in the Archive section.

Wednesday, July 11, 2007

Emami - Good Results

Emami FY07 PBT Up 44% On Strong Exports

Emami, one of the leading players in the personal and health care industry, reported a 44% growth in profit before tax (PBT) at Rs 74.5 crore for the year ended March 31, 2007 (FY07) as against Rs 51.6 crore in FY06.

The turnover for the company grew 27% at Rs 516 crore as compared to Rs 407 crore in FY06. Emami attributed this growth to its growing FMCG business and newer launches last financial year.

During the quarter, the company saw 39.91% rise in profit to Rs 221.90 million from Rs 158.60 million during the quarter ended March 2006.

Net sales for the quarter rose 54.24% to Rs 1,499.40 million from Rs 972.1 million during the corresponding quarter, a year ago.

Operating margins fell to 14.12% during the quarter, a fall of 24.17 basis points compared with the corresponding quarter, a year ago. Net margins, on the other hand, fell to 14.74% during the quarter from 16.24% in the same period last year.

The brands Navratna Oil and Boroplus Antiseptic Cream with market shares of 55.2% and 69.7% respectively, strengthened Emami's position further.

Mr Black & Mrs Black Hair Dye Powder and Malai Kesar Cold Cream were the most recent launches and accounted for 17% of turnover.

Emami's international business grew by 40%. This growth is from all 59 countries that it exports to, specially SAARC, Africa and Europe. Emami's new international range of products, Emita range, aimed at the masses in developing countries and the Gold range and Ayucare range, aimed at niche and premium markets, received excellent market response.

Labels: Emami

0 Comments:

DISCLAIMER

This Document is subject to changes without prior notice and is intended only for the person or entity to which it is addressed to and may contain confidential and/or privileged material and is not for any type of circulation. Any review, retransmission, or any other use is prohibited. Kindly note that this document does not constitute an offer or solicitation for the purchase or sale of any financial instrument or as an official confirmation of any transaction.

The information contained herein is from publicly available data or other sources believed to be reliable. While I would endeavour to update the information herein on reasonable basis, I am under no obligation to update or keep the information current. Also, there may be regulatory, compliance, or other reasons that may prevent me from doing so. I do not represent that information contained herein is accurate or complete and it should not be relied upon as such. This document is prepared for assistance only and is not intended to be and must not alone betaken as the basis for an investment decision. The user assumes the entire risk of any use made of this information. Each recipient of this document should make such investigations as it deems necessary to arrive at an independent evaluation of an investment in the securities of companies referred to in this document (including the merits and risks involved), and should consult its own advisors to determine the merits and risks of such an investment. The investment discussed or views expressed may not be suitable for all investors. I do not undertake to advise you as to any change of my views. I may have issued other reports that are inconsistent with and reach different conclusion from the information presented in this report. This report is not directed or intended for distribution to, or use by, any person or entity who is a citizen or resident of or located in any locality, state, country or other jurisdiction, where such distribution, publication, availability or use would be contrary to law, regulation or which would subject me to any registration or licensing requirement within such jurisdiction. The securities described herein may or may not be eligible for sale in all jurisdictions or to certain category of investors. Persons in whose possession this document may come are required to inform themselves of and to observe such restriction. I may have used the information set forth herein before publication and may have positions in, may from time to time purchase or sell or may be materially interested in any of the securities mentioned or related securities. I may from time to time solicit from, or perform investment banking, or other services for, any company mentioned herein. Without limiting any of the foregoing, in no event shall I or any third party involved in, or related to, computing or compiling the information have any liability for any damages of any kind.